Related Experiment Video
Updated: May 13, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells
Tanya Pike1, Charlotte Widberg, Andrew Goodall
1The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Abstract:
The primary endpoint of signalling through the canonical Raf-MEK-ERK MAP kinase cascade is ERK activation. Here we report a novel signalling outcome for this pathway. Activation of the MAP kinase pathway by growth factors or phorbol esters during G2 phase results in only transient activations of ERK and p90RSK, then suppression to below control levels. A small peak of ERK and p90RSK activation in early G2 phase cells was identified, and inhibition of this delayed entry into mitosis. The previously identified, proteolytically cleaved form of MEK1 termed tMEK (truncated MEK1), is also induced with G2 phase MAPK pathway activation. We demonstrate that addition of recombinant mutants of MEK1 with an N-terminal truncation similar to that of tMEK also inhibited ERK and p90RSK activations and delayed progression into mitosis. Only catalytically inactive forms of tMEK were capable of these effects, but surprisingly, phosphorylation on the activating Ser218/222 sites was also required. A lack of MEK1 or ability to accumulate tMEK resulted in the absence of the feedback inhibition of ERK and p90RSK activations. tMEK is a novel output from the canonical MAP kinase signalling pathway, acting in a MAPK signalling-regulated dominant negative manner to inhibit ERK and p90RSK activations, acting as a dampening mechanism to reduce the magnitude or duration of MAPK pathway signalling in G2/M phase.
Insights
A novel truncated form of MEK1 (tMEK) acts as a feedback inhibitor in the MAP kinase pathway. This tMEK dampens ERK and p90RSK activation during G2/M phase, regulating cell cycle progression.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Signal Transduction
Background:
- The canonical Raf-MEK-ERK MAP kinase cascade is crucial for cellular responses.
- ERK activation is a primary endpoint, but its regulation, especially during cell cycle phases like G2, is complex.
Purpose of the Study:
- To investigate a novel signaling outcome of the MAP kinase pathway during G2 phase.
- To elucidate the role of truncated MEK1 (tMEK) in regulating MAP kinase signaling and cell cycle progression.
Main Methods:
- Stimulation of MAP kinase pathway using growth factors or phorbol esters during G2 phase.
- Analysis of ERK and p90RSK activation dynamics.
- Expression and functional analysis of recombinant MEK1 mutants, including catalytically inactive and phosphorylated forms.
- Assessment of tMEK accumulation and its impact on signaling and mitosis.
Main Results:
- MAP kinase pathway activation in G2 phase leads to transient ERK and p90RSK activation followed by suppression.
- A novel truncated form of MEK1 (tMEK) is induced upon G2 phase MAP kinase activation.
- Catalytically inactive but phosphorylated tMEK mutants inhibit ERK and p90RSK activation and delay mitosis.
- Lack of MEK1 or tMEK accumulation abrogates feedback inhibition of ERK and p90RSK.
Conclusions:
- tMEK is a novel output of the MAP kinase pathway, functioning as a negative feedback regulator.
- tMEK dampens the magnitude and duration of MAP kinase signaling during G2/M phase.
- This mechanism plays a role in controlling cell cycle progression by modulating ERK and p90RSK activity.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Related Concept Videos
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
Positive Regulator Molecules
Positive Regulator Molecules